Living donor transplant recipients donor selection. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy9

Transplants Antilymphocyte Serum Hepatic Veins Portal Vein Liver Kidney Hepatic Artery Bile Ducts T-Lymphocytes

Organisms3

Cytomegalovirus BK Virus Mice, Inbred C57BL

Diseases33

Cadaver Graft vs Host Disease Postoperative Complications Liver Failure Cytomegalovirus Infections Blood Group Incompatibility Kidney Failure, Chronic Liver Diseases Bronchiolitis Obliterans Opportunistic Infections Delayed Graft Function Brain Death Polyomavirus Infections End Stage Liver Disease Recurrence Lymphoproliferative Disorders Mycoses Biliary Atresia Kidney Diseases Hepatitis C Biliary Tract Diseases Infection Liver Cirrhosis Acute Disease Renal Insufficiency Aspergillosis Primary Graft Dysfunction Constriction, Pathologic Liver Neoplasms Hematologic Neoplasms Liver Failure, Acute Carcinoma, Hepatocellular Viremia

Chemicals and Drugs17

Immunosuppressive Agents Tacrolimus HLA Antigens Cyclosporine Antilymphocyte Serum Mycophenolic Acid ABO Blood-Group System Ganciclovir Creatinine Isoantibodies Antiviral Agents Azathioprine Sirolimus Calcineurin Antifungal Agents Biological Markers DNA, Viral

Analytical, Diagnostic and Therapeutic Techniques and Equipment54

Donor Selection Kidney Transplantation Liver Transplantation Histocompatibility Testing Transplantation, Homologous Bone Marrow Transplantation Treatment Outcome Transplantation Hematopoietic Stem Cell Transplantation Retrospective Studies Heart Transplantation Organ Transplantation Lung Transplantation Tissue and Organ Harvesting Immunosuppression Hepatectomy Risk Factors Survival Rate Transplantation Conditioning Whole-Body Irradiation Survival Analysis Follow-Up Studies Pancreas Transplantation Patient Selection Heart-Lung Transplantation Postoperative Period Biopsy Anastomosis, Surgical Prospective Studies Incidence Cohort Studies Nephrectomy Risk Assessment Fatal Outcome Biliary Tract Surgical Procedures Multivariate Analysis Kaplan-Meier Estimate Glomerular Filtration Rate Drug Therapy, Combination Polymerase Chain Reaction Reconstructive Surgical Procedures Kidney Function Tests Proportional Hazards Models Reoperation Chi-Square Distribution Prognosis Liver Function Tests Cold Ischemia Registries Plasmapheresis Transplantation, Heterotopic Predictive Value of Tests Drug Monitoring Tomography, X-Ray Computed

Psychiatry and Psychology2

Altruism Gift Giving

Phenomena and Processes12

Graft Survival Graft Rejection Histocompatibility Selection, Genetic Time Factors Immunocompromised Host Transplantation Immunology Liver Circulation Glomerular Filtration Rate Transplantation Tolerance Chi-Square Distribution Liver Regeneration

Information Science5

Survival Rate Incidence Fatal Outcome Molecular Sequence Data Registries

Named Groups4

Living Donors Tissue Donors Blood Donors Unrelated Donors

Health Care24

Donor Selection Tissue and Organ Procurement Treatment Outcome Directed Tissue Donation Waiting Lists Retrospective Studies Risk Factors Survival Rate Survival Analysis Follow-Up Studies Patient Selection Postoperative Period Prospective Studies Incidence Cohort Studies Risk Assessment Fatal Outcome Multivariate Analysis Kaplan-Meier Estimate Age Factors Proportional Hazards Models Chi-Square Distribution Registries Predictive Value of Tests

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Information Science Named Groups Health Care Geographicals

Living Donors Donor Selection Kidney Transplantation Tissue and Organ Procurement Cadaver Tissue Donors Liver Transplantation Graft Survival Histocompatibility Testing Graft Rejection Transplantation, Homologous Histocompatibility Blood Donors Immunosuppressive Agents Bone Marrow Transplantation Treatment Outcome Graft vs Host Disease Transplantation Directed Tissue Donation Hematopoietic Stem Cell Transplantation Waiting Lists Transplants Retrospective Studies Heart Transplantation Organ Transplantation Lung Transplantation Selection, Genetic Time Factors Postoperative Complications Liver Failure Tacrolimus HLA Antigens Tissue and Organ Harvesting Cyclosporine Immunosuppression Antilymphocyte Serum Cytomegalovirus Infections Hepatectomy Hepatic Veins Unrelated Donors Risk Factors Mycophenolic Acid Survival Rate Transplantation Conditioning Immunocompromised Host Whole-Body Irradiation Survival Analysis Transplantation Immunology Follow-Up Studies Blood Group Incompatibility Kidney Failure, Chronic Pancreas Transplantation Liver Diseases Cytomegalovirus Patient Selection Heart-Lung Transplantation BK Virus Portal Vein Bronchiolitis Obliterans Opportunistic Infections Postoperative Period ABO Blood-Group System Ganciclovir Biopsy Delayed Graft Function Brain Death Anastomosis, Surgical Prospective Studies Liver Kidney Polyomavirus Infections Creatinine End Stage Liver Disease Isoantibodies Recurrence Incidence Antiviral Agents Hepatic Artery Cohort Studies Nephrectomy Risk Assessment Liver Circulation Lymphoproliferative Disorders Mycoses Fatal Outcome Biliary Atresia Kidney Diseases Biliary Tract Surgical Procedures Multivariate Analysis Kaplan-Meier Estimate Azathioprine Hepatitis C Biliary Tract Diseases Altruism Glomerular Filtration Rate Drug Therapy, Combination Sirolimus Age Factors Polymerase Chain Reaction Reconstructive Surgical Procedures

No FAQ available that match "living donor transplant recipients donor selection"